Orphazyme A/S sell Amped
Start price
21.06.21
/
0%
€6.30
Target price
21.06.22
-
Performance (%)
9.52%
End price
23.06.21
€6.90
Summary
This prediction ended on 23.06.21 with a price of €6.90. With a performance of 9.52%, the SELL prediction by Amped for Orphazyme A/S was trending in the wrong direction This prediction was marked as speculative and is excluded from Amped's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Orphazyme A/S | - | - | - |
iShares Core DAX® | -0.922% | -1.993% | 13.399% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to Amped what are the pros and cons of Orphazyme A/S for the foreseeable future?
Pros
EBIT growth >5% per year expected
Capable Management
Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Good culture
Sustainability is important
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Few uniques
Dependend from some customers or products
Significant cyclical dependencies
Comments by Amped for this prediction
In the thread Orphazyme A/s diskutieren
Sell Orphazyme A/S
In the thread Trading Orphazyme A/s
Sell beendet
Stopped prediction by Amped for Orphazyme A/S
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.80
25.06.21
25.06.21
-
21.06.22
21.06.22
-88.60%
22.06.22
22.06.22
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€0.78
25.06.21
25.06.21
-
21.06.22
21.06.22
-
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.90
23.06.21
23.06.21
-
21.06.22
21.06.22
-1.45%
25.06.21
25.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products
Orphazyme A/S
Start price
Target price
Perf. (%)
€6.55
21.06.21
21.06.21
-
21.06.22
21.06.22
-3.82%
21.06.21
21.06.21
EBIT growth >5% per year expected
Capable Management
Few uniques
Dependend from some customers or products